Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteoporosis × Letrozole × Clear all

Phase

Phase NA 2 Phase 3 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 143 Endometrial Neoplasms 13 Ovarian Neoplasms 12 Fallopian Tube Neoplasms 5 Recurrence 4 Neoplasms 4 Neoplasm Metastasis 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Cancer Metastatic 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Leiomyosarcoma 2 Carcinoma, Lobular 2 Breast Diseases 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Polycystic Ovary Syndrome 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Neoplastic Cells, Circulating 1 Neoadjuvant Operable Breast Cancer 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphangioleiomyomatosis 1

Interventions

Zoledronic Acid 4 xian ling gu bao 1 Testosterone 1 Observation 1 Linseed Oil 1 Letrozole 1 Cholecalciferol 1 Calcium Gluconate 1 Calcium Citrate 1 Calcium Carbonate 1 Calcium 1 Adrenalectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02455154 2020-04-14

COAT

Shanghai Jiao Tong University School of Medicine

Phase 2 Completed

Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡